ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRM Proteome Sciences Plc

3.25
0.18 (5.86%)
12 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.18 5.86% 3.25 148,375 16:35:22
Bid Price Offer Price High Price Low Price Open Price
2.50 4.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 7.78M 1.33M 0.0045 6.82 9.06M
Last Trade Time Trade Type Trade Size Trade Price Currency
15:07:44 O 43,375 2.82 GBX

Proteome Sciences (PRM) Latest News

Proteome Sciences (PRM) Discussions and Chat

Proteome Sciences (PRM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Proteome Sciences (PRM) Top Chat Posts

Top Posts
Posted at 13/4/2024 09:20 by Proteome Sciences Daily Update
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 3.07p.
Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £9,062,089.
Proteome Sciences has a price to earnings ratio (PE ratio) of 6.82.
This morning PRM shares opened at -
Posted at 12/4/2024 16:51 by elpirata
I note that cjp's loan with interest accruing is now £11.235m & prm has an mcap just over £9m
Posted at 10/4/2024 10:02 by pools2
wasjobber,

Thermo have been a long term partner of Proteome Sciences for 15 years, but I agree it'll be good to see Thermo taking a more prominent position. After reading the RNS this morning, the future looks brighter than ever.

You've already mentioned what I think is probably the most significant RNS statement:-

"It's very interesting that PRM are now openly stating that their patented Alzheimer's and cancer biomarkers may be critical to new diagnostics and treatment moving forward.

STRONG BUY"

It's very significant for Proteome Sciences to say that.

The value of these biomarkers will be considerable and will project PRM into the £100 millions plus market cap. with ease.

I think you are now correct, we are at a pivotal moment for the share price and investors buying now will achieve significant returns, possibly quicker than some may think.
Posted at 05/4/2024 07:25 by peverill
Are pools and wasjobber one and the same.They have a knack of both putting 2+2 together to make 5.Where anywhere does it say the NHS are using PRM markers in these trials,Given PRM's precarious position you would think they would be shouting from the rooftops if true.
Posted at 02/4/2024 16:45 by dominiccummings
I understand that Sam Beckett based his play "Waiting for Godot" on his experience as a small PRM shareholder.
Posted at 28/3/2024 15:12 by barry evans
PramBigear 3 Jul '06 - 20:11 - 38468 of 61525 0 0 0

Give it a rest Goatherd!
"However I find Peter's theories and posts far more likely than yours. You sit on the fence and bleat. He posts what he believes - it is simply up to his readers what they do.
It is possible that you will cost posters vastly more than Peter ever will."

Jeffian's logical posts are certainly as valid as "Peter's theories" and certainly could not COST posters more than Peter's ever will, for Jeffian's implicit message is "don't risk your cash" whilst Peter's is "fill yer boots".

You can only lose money that you already have. Miss an opportunity, perhaps, but that is not a COST.


jeffian3 Jul '06 - 22:59 - 38472 of 61525 0 0 0

Richard,

As Pram points out, a potential profit foregone is not exactly the same as a loss! When Peter said on 27/1/04 "we can be sure that the value of PRM shares will soon far exceed the £8 that Tuco forecast in his recent post" and encouraged people to buy, the share price was around 215. If it fulfilled Peter's best expectations tomorrow by 5-bagging without any opportunity to buy on the way up....then people who took his advice then would just about break even while followers of the Bar Room Monkey tendency would be in the same boat. I call that even-stevens. If, on the other hand, Peter's best expectations are not met, some people out there are nursing a nasty loss. That also presupposes that there will be no opportunity to climb aboard when/if it becomes clear that the potential is being turned into £££ but this flies in the face of the evidence of most major long-term growth stories from Microsoft downwards as a glimpse at their share charts will show. To take your point of a 'potential' £53 valuation over time, other than how stinking rich you want to be, it doesn't matter much whether you climb aboard at 39, 45, 60, £1 or £2, you're still going to do OK.

Obviously my approach is more risk-averse but it concerns me that Peter's posts, however honestly held his views, go beyond just presenting his argument to stating that it is only our own stupidity which prevents us from drawing the same conclusions and specifically encouraging people to buy - and they have. As you say, "it is simply up to his readers what they do" but it doesn't hurt to remind them of the alternatives. Having made a bit of money, I like 'not losing it' almost as much as making more!

In a wider context, as ever PRM-ers are following parallel (but not necessarily convergent!) courses with those of a 'scientific' bent hanging on the perceived progress of the IP while the BRM's want evidence to back up the claims - made by the company itself since 2003 remember - that it can be converted into a highly cash-generative asset. I have seen this so may times with shares like SPS, NTX, TRK, GHT etc. which have all had flurries of excitement having unique technology which should have given them access to vast markets but they've overpromised and underdelivered and the City won't rate them until the £££'s roll in. It's the same with this one and, whilst you may not like me saying it, a glance at the chart shows that if I'm 'wrong' I'm not alone so I may be some use to you contra-cyclical types to show you how the wider market is thinking!

Finally, Richard, in your obsession with traders/shorters, you tend to see everything in terms of 'Buy' or 'Sell' but there is a perfectly respectable position called 'Hold', which is what I've been doing since Feb 2000. Or "sitting on the fence" as you call it.

Regards, Ian
Posted at 07/3/2024 18:40 by wrighty41
The current CEO of PRM is proving herself to be uninspiring imo.
I’m still hopeful we may see 6p+ on the share price this year but without any update from PRM on the forward looking revenue outlook for 2024 it’s difficult to say.
We’ll get the FY results over next couple of months. The forward guidance will be critical for share price progress.
W41
Posted at 14/2/2024 19:59 by peverill
Does Richard not remember he sold out a few years ago,bought back in near 6p ish and now claiming he made a significant profit when the share price has been in the doldrums for the last 5 years.Even with dynamic Mrs S at the helm being unable to budge the price despite picking up over a million in wages and taking the company back 10 years and putting numerous investors on the breadline.
Posted at 14/2/2024 14:05 by elpirata
good post pev

peverill 14 Feb '24 - 13:28 - 92720 of 92720
0 1 0
Nobody hates PRM,the problem lies with the total lack of movement in the 25 years they have been on the go,30 plus years counting electrophoretics.They have achieved nothing,seen countless CEO’s come and go because their hands are tied by a clueless back staff.amassed a library of useless patents that no one needs and have a happy clapping following of equally clueless investors who’s excuses lie between it’s not happened yet and we don’t have money to progress anything but we should be worth £54 a share if we sit here and wait for someone to infringe a patent.Like I said the US move is the last throw of the dice,PRM are getting left behind by more advanced and dynamic companies.
Posted at 14/2/2024 13:28 by peverill
Nobody hates PRM,the problem lies with the total lack of movement in the 25 years they have been on the go,30 plus years counting electrophoretics.They have achieved nothing,seen countless CEO's come and go because their hands are tied by a clueless back staff.amassed a library of useless patents that no one needs and have a happy clapping following of equally clueless investors who's excuses lie between it's not happened yet and we don't have money to progress anything but we should be worth £54 a share if we sit here and wait for someone to infringe a patent.Like I said the US move is the last throw of the dice,PRM are getting left behind by more advanced and dynamic companies.
Posted at 13/2/2024 14:52 by pools2
wasjobber,

I agree and as PRM continue to receive patent grants for their newer Alzheimer's disease patent portfolio we could also see some significant moves in the share price as large value deals in Alzheimer's disease are completed.
Proteome Sciences share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock